Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2012

01.10.2012 | Gynecologic Oncology

Prevalence of HPV infection and genotypes in women with normal cervical cytology in the state of Paraná, Brazil

verfasst von: Mariana Clivati da Silva, Helen Priscila Rodrigues Martins, Jamile Lopes de Souza, Maria Cristina Bronharo Tognim, Terezinha Inez Estivalet Svidzinski, Jorge Juarez Vieira Teixeira, Marcia Edilaine Lopes Consolaro

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Objective

We investigated the prevalence of the human Papillomavirus (HPV) and its genotypes in women with normal cervical cytology in the state of Paraná, Brazil, and also epidemiological characteristics.

Methods

The enrolled patients were seen at six primary health-care units in Paiçandú City, Paraná. Through polymerase chain reaction (PCR) and PCR–RFLP (restriction fragment length polymorphism) techniques, 40 HPV genotypes were found, including 15 high risk, 3 undetermined risk and 22 low risk. Socio-demographic characteristics and sexual behavior were also recorded by interviews based on a structured questionnaire completed at the time of enrollment.

Results

Among 418 patients examined, HPV was detected in 6.7 %, mainly in women aged <25 years. The overall prevalence of high-risk, low-risk and undetermined-risk HPV types was 42.9, 45.7, and 11.7 %, respectively. HPV-16 was the most common type detected (14.3 %), followed by types 66 (11.4 %) and 31 and 70 (8.6 % each). Detection of HPV DNA was positively associated with the number of sexual partners within the previous 12 months (p < 0.031; OR = 5.4; CI = 0.98–29.8).

Conclusion

When considering the lack of studies in Paraná on women with normal cytology, the results of this study will improve estimates of HPV DNA populations, and provide baseline values against which the impact of vaccination can be assessed in the future.
Literatur
1.
Zurück zum Zitat Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917PubMedCrossRef Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917PubMedCrossRef
2.
Zurück zum Zitat Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE (2011) Human Papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 103:1–16CrossRef Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE (2011) Human Papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 103:1–16CrossRef
4.
Zurück zum Zitat Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK et al (1999) Relation of Human Papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354:20–25PubMedCrossRef Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK et al (1999) Relation of Human Papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354:20–25PubMedCrossRef
5.
Zurück zum Zitat Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S (2010) Cervical Human Papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202:1789–1799PubMedCrossRef Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S (2010) Cervical Human Papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202:1789–1799PubMedCrossRef
6.
Zurück zum Zitat de Sanjose S, Almirall R, Lloveras B, Font R, Diaz M, Muñoz N et al (2007) Worldwide prevalence and genotype distribution of cervical human Papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7:453–459PubMedCrossRef de Sanjose S, Almirall R, Lloveras B, Font R, Diaz M, Muñoz N et al (2007) Worldwide prevalence and genotype distribution of cervical human Papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7:453–459PubMedCrossRef
7.
Zurück zum Zitat Forinash AB, Yancey AM, Pitlick JM, Myles TD (2011) Safety of the HPV bivalent and quadrivalent vaccines during pregnancy. Ann Pharmacother 45:258–262 Forinash AB, Yancey AM, Pitlick JM, Myles TD (2011) Safety of the HPV bivalent and quadrivalent vaccines during pregnancy. Ann Pharmacother 45:258–262
10.
Zurück zum Zitat Solomon D, Nayar R (2005) Bethesda system for cervical–vaginal cytology. Revinter, Rio de Janeiro, pp 67–87 Solomon D, Nayar R (2005) Bethesda system for cervical–vaginal cytology. Revinter, Rio de Janeiro, pp 67–87
11.
Zurück zum Zitat Qu W, Jiang G, Cruz Y, Chang CJ, Ho GYF, Klein R et al (1997) PCR detection of human Papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35:1304–1310PubMed Qu W, Jiang G, Cruz Y, Chang CJ, Ho GYF, Klein R et al (1997) PCR detection of human Papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35:1304–1310PubMed
12.
Zurück zum Zitat Santiago E, Camacho L, Junquera ML, Vásquez F (2006) Full HPV typing by a single restriction enzyme. J Clin Virol 37:38–46PubMedCrossRef Santiago E, Camacho L, Junquera ML, Vásquez F (2006) Full HPV typing by a single restriction enzyme. J Clin Virol 37:38–46PubMedCrossRef
13.
Zurück zum Zitat Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366:991–998PubMedCrossRef Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366:991–998PubMedCrossRef
14.
Zurück zum Zitat Lorenzato F, Ho L, Terry G, Singer A, Santos LC, Lucena BR et al (2000) The use of women papillomavirus in detection of cervical neoplasia in Recife (Brazil). Int J Gynecol Cancer 10:143–150PubMedCrossRef Lorenzato F, Ho L, Terry G, Singer A, Santos LC, Lucena BR et al (2000) The use of women papillomavirus in detection of cervical neoplasia in Recife (Brazil). Int J Gynecol Cancer 10:143–150PubMedCrossRef
15.
Zurück zum Zitat Krambeck WM, Candidé RM, Dalmaco EM, de Cordova CM (2008) HPV detection and genotyping as an earlier approach in cervical cancer screening of the female genital tract. Clin Exp Obstet Gynecol 35:175–178PubMed Krambeck WM, Candidé RM, Dalmaco EM, de Cordova CM (2008) HPV detection and genotyping as an earlier approach in cervical cancer screening of the female genital tract. Clin Exp Obstet Gynecol 35:175–178PubMed
16.
Zurück zum Zitat Lippeman SA, Sucupira MCA, Jones HE, Luppi CG, Palefsky J, Van de Wiigert JHHM, Oliveira RLS, Diaz RS (2010) Frequence, distribution and correlates of endocervical human papillomavirus types in Brazilian women. Int J STD AIDS 21:105–109CrossRef Lippeman SA, Sucupira MCA, Jones HE, Luppi CG, Palefsky J, Van de Wiigert JHHM, Oliveira RLS, Diaz RS (2010) Frequence, distribution and correlates of endocervical human papillomavirus types in Brazilian women. Int J STD AIDS 21:105–109CrossRef
17.
Zurück zum Zitat Rosa MI, Fachel JMG, Rosa DD, Medeiros LR, Igansi CN, Bozzetti MC (2008) Persistence and clearance of human papillomavirus infection: a prospective cohort study. Am J Obstet Gynecol 99:1–7 Rosa MI, Fachel JMG, Rosa DD, Medeiros LR, Igansi CN, Bozzetti MC (2008) Persistence and clearance of human papillomavirus infection: a prospective cohort study. Am J Obstet Gynecol 99:1–7
18.
Zurück zum Zitat Fernandes JV, Meissner RV, Carvalho MGF, Fernandes TAAM, Azevedo PRM, Villa L (2009) Prevalence of HPV infection by cervical cytologic status in Brazil. Int J Gynaecol Obstet 105:21–24PubMedCrossRef Fernandes JV, Meissner RV, Carvalho MGF, Fernandes TAAM, Azevedo PRM, Villa L (2009) Prevalence of HPV infection by cervical cytologic status in Brazil. Int J Gynaecol Obstet 105:21–24PubMedCrossRef
19.
Zurück zum Zitat Rossi PG, Bisanzi S, Paganini I, Di Lasi A, Angeloni C, Scalisi A et al (2010) Frequency of HPV high and low risk types in cervical samples from the Italian general population: a population based study. BMC Infect Dis 10:1–13CrossRef Rossi PG, Bisanzi S, Paganini I, Di Lasi A, Angeloni C, Scalisi A et al (2010) Frequency of HPV high and low risk types in cervical samples from the Italian general population: a population based study. BMC Infect Dis 10:1–13CrossRef
20.
Zurück zum Zitat Uusküla A, Kals M, Kosenkranius L, McNutt LA, DeHovitz (2010) Population-based type-specific frequency of high-risk human papillomavirus infection in Estonia. BMC Infect Dis 10:1–8CrossRef Uusküla A, Kals M, Kosenkranius L, McNutt LA, DeHovitz (2010) Population-based type-specific frequency of high-risk human papillomavirus infection in Estonia. BMC Infect Dis 10:1–8CrossRef
21.
Zurück zum Zitat Gontijo RC, Derchain SF, Roteli-Martins C, Bragança JF, Sarian LO, Morais SS et al (2007) Human Papillomavirus (HPV) infections as risk factors for cytological and histological abnormalities in baseline PAP smear-negative women followed-up for 2 years in the LAMS study. Eur J Obstet Gynecol Reprod Biol 133:239–246PubMedCrossRef Gontijo RC, Derchain SF, Roteli-Martins C, Bragança JF, Sarian LO, Morais SS et al (2007) Human Papillomavirus (HPV) infections as risk factors for cytological and histological abnormalities in baseline PAP smear-negative women followed-up for 2 years in the LAMS study. Eur J Obstet Gynecol Reprod Biol 133:239–246PubMedCrossRef
22.
Zurück zum Zitat de Sanjose S, Almirall R, Lloveras B, Font R, Diaz M, Muñoz M et al (2003) Cervical human Papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 30:788–793PubMedCrossRef de Sanjose S, Almirall R, Lloveras B, Font R, Diaz M, Muñoz M et al (2003) Cervical human Papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 30:788–793PubMedCrossRef
23.
24.
Zurück zum Zitat Kjær SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T (2008) Population-based frequency, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 123:1864–1870PubMedCrossRef Kjær SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T (2008) Population-based frequency, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 123:1864–1870PubMedCrossRef
25.
Zurück zum Zitat Molano M, Posso H, Weiderpass E, van den Brule AJC, Ronderos M, Franceschi S et al (2002) Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 87:324–333PubMedCrossRef Molano M, Posso H, Weiderpass E, van den Brule AJC, Ronderos M, Franceschi S et al (2002) Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 87:324–333PubMedCrossRef
26.
Zurück zum Zitat Stamataki P, Papazafiroupoulou A, Elefsiniostis I, Giannakopoulous M, Brokalaki H, Apostolopoulou E et al (2010) Prevalence of HPV infection among Greek women attending a gynecological outpatient clinic. BMC Infect Dis 10:1–6CrossRef Stamataki P, Papazafiroupoulou A, Elefsiniostis I, Giannakopoulous M, Brokalaki H, Apostolopoulou E et al (2010) Prevalence of HPV infection among Greek women attending a gynecological outpatient clinic. BMC Infect Dis 10:1–6CrossRef
27.
Zurück zum Zitat Confortini M, Carozzi F, Zappa M, Ventura L, Iossa A, Cariagge P et al (2010) Human Papillomavirus infection and risk factors in a cohort of Tuscan woman aged 18–24: results at recruitment. BMC Infect Dis 10:1–11CrossRef Confortini M, Carozzi F, Zappa M, Ventura L, Iossa A, Cariagge P et al (2010) Human Papillomavirus infection and risk factors in a cohort of Tuscan woman aged 18–24: results at recruitment. BMC Infect Dis 10:1–11CrossRef
Metadaten
Titel
Prevalence of HPV infection and genotypes in women with normal cervical cytology in the state of Paraná, Brazil
verfasst von
Mariana Clivati da Silva
Helen Priscila Rodrigues Martins
Jamile Lopes de Souza
Maria Cristina Bronharo Tognim
Terezinha Inez Estivalet Svidzinski
Jorge Juarez Vieira Teixeira
Marcia Edilaine Lopes Consolaro
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2012
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-012-2399-y

Weitere Artikel der Ausgabe 4/2012

Archives of Gynecology and Obstetrics 4/2012 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.